We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$25.3M
Cap. Flow
+$32.9M
Cap. Flow %
8.36%
Top 10 Hldgs %
80.79%
Holding
223
New
14
Increased
85
Reduced
52
Closed
29

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$10.8M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$10.2M
3
MCRB icon
Seres Therapeutics
MCRB
+$1.62M
4
VUZI icon
Vuzix
VUZI
+$1.34M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.16M

Top Sells

Rank Stock Value
1
OUST icon
Ouster
OUST
+$1.06M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.02M
3
TVTX icon
Travere Therapeutics
TVTX
+$897K
4
ADCT icon
ADC Therapeutics
ADCT
+$633K
5
RBOT
Vicarious Surgical
RBOT
+$548K

Sector Composition

Rank Sector Weight
1 Real Estate 18.05%
2 Healthcare 12.08%
3 Technology 1.59%
4 Financials 1.03%
5 Industrials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHMI
201
Cherry Hill Mortgage Investment Corp
CHMI
$86.3M
– –
-10,977
Closed -$108K
CIM
202
Chimera Investment
CIM
$1.08B
– –
-5,254
Closed -$237K
ECH icon
203
iShares MSCI Chile ETF
ECH
$1.01B
– –
-2,774
Closed -$80K
EIDO icon
204
iShares MSCI Indonesia ETF
EIDO
$473M
– –
-1,783
Closed -$36K
EWM icon
205
iShares MSCI Malaysia ETF
EWM
$311M
– –
-199
Closed -$5K
EWY icon
206
iShares MSCI South Korea ETF
EWY
$19.3B
– –
-1,241
Closed -$116K
EWZ icon
207
iShares MSCI Brazil ETF
EWZ
$9.1B
– –
-2,936
Closed -$119K
FXI icon
208
iShares China Large-Cap ETF
FXI
$4.6B
– –
-2,000
Closed -$93K
HYD icon
209
VanEck High Yield Muni ETF
HYD
$4.49B
– –
-2,445
Closed -$156K
HYMB icon
210
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.08B
– –
-5,110
Closed -$155K
KNSA icon
211
Kiniksa Pharmaceuticals
KNSA
$4.92B
– –
-32,500
Closed -$453K
MAV
212
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
– –
-13,500
Closed -$167K
OUST icon
213
Ouster
OUST
$2.49B
– –
-8,500
Closed -$1.06M
PFE icon
214
Pfizer
PFE
$143B
– –
-2,000
Closed -$78K
RBOT
215
DELISTED
Vicarious Surgical
RBOT
– –
-1,833
Closed -$548K
SHYD icon
216
VanEck Short High Yield Muni ETF
SHYD
$450M
– –
-6,105
Closed -$155K
TAK icon
217
Takeda Pharmaceutical
TAK
$54.8B
– –
-2,200
Closed -$37K
TVTX icon
218
Travere Therapeutics
TVTX
$5.27B
– –
-61,500
Closed -$897K
CYT
219
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
– –
-1,000
Closed -$21K
TMDI
220
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
– –
-150,000
Closed -$257K
RVI
221
DELISTED
Retail Value Inc. Common Shares
RVI
– –
-84,835
Closed -$169K
KDMN
222
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-45,500
Closed -$176K
IPFF
223
DELISTED
iShares International Preferred Stock ETF
IPFF
– –
-13,040
Closed -$224K
5 6 7 8
9

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, AlphaCentric Advisors held 223 positions worth $393M, up 6.9% from $368M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

AlphaCentric Advisors deployed $32.9M of net new capital in Q3 2021, opening 14 new positions and adding to 85 existing holdings. Its largest new stake was Seres Therapeutics: 8,275 shares worth $1.15M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $1.02M trimmed.

  • AlphaCentric Advisors's largest Q3 2021 buy was Seres Therapeutics: 8,275 shares worth $1.15M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2021, an estimated $10.8M increase.
  • AlphaCentric Advisors's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.02M.
  • AlphaCentric Advisors fully exited Ouster in Q3 2021, selling an estimated $1.06M.
  • AlphaCentric Advisors's ten largest holdings make up 81% of its $393M portfolio in Q3 2021.
  • AlphaCentric Advisors opened 14 new positions and closed 29 in Q3 2021.
  • AlphaCentric Advisors's portfolio value rose 6.9% quarter-over-quarter to $393M.

Based on AlphaCentric Advisors's 13F filing for Q3 2021, filed 9 Mar 2022.